Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity

BACKGROUND: Retinopathy of prematurity (ROP) is one of the common complications of prematurity. Intravitreal injection of ranibizumab (IVR), an antivascular endothelial growth factor (VEGF) drug, showed significant benefit for ROP. However, there are concerns about systemic complications of anti-VEG...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Ophthalmol
Autors principals: Chen, Xuting, Zhou, Lin, Zhang, Qi, Xu, Yu, Zhao, Peiquan, Xia, Hongping
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545787/
https://ncbi.nlm.nih.gov/pubmed/31236289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/2985161
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars